Christian Gröndahl
Directeur Général chez SNIPR Biome ApS
Profil
Christian Grøndahl is the founder of SNIPR Biome ApS, which was founded in 2017, where he holds the title of Chief Executive Officer.
He currently holds positions at Tubulis GmbH as Independent Chairman-Supervisory Board and at Vitrolife A as Director.
Dr. Grøndahl's former positions include Chief Executive Officer & Director at Kymab Ltd., Chairman at Setisila Oy, Director at Kongeriget Danmarks.
Hesteforsikring G, Director at Freeline Therapeutics Ltd., Vice President-Cancer & Inflammation at Novo Nordisk A from 1996 to 2010, and Chief Scientific Officer & EVP at Zealand Pharma A in 2012.
Dr. Grøndahl holds a doctorate from the University of Copenhagen and an MBA from the International Institute for Management Development.
Postes actifs de Christian Gröndahl
| Sociétés | Poste | Début |
|---|---|---|
Vitrolife A/S
 Vitrolife A/S Industrial MachineryProducer Manufacturing Part of Vitrolife AB, Vitrolife A/S is a Danish company that manufactures laboratory equipment and customizes software. The company is based in Aarhus, Denmark. Kjær Andreasen has been the CEO of the company since 2014. Vitrolife was acquired by Vitrolife AB on November 26, 2014 for $84.11 million. | Directeur/Membre du Conseil | - |
SNIPR Biome ApS
 SNIPR Biome ApS Pharmaceuticals: MajorHealth Technology SNIPR Biome ApS develops bacterial composition to provide treatment for diabetes to cancer. The company was founded by Christian Grøndal and is headquartered in Kongens Lyngby, Denmark. | Directeur Général | 11/08/2017 |
Tubulis GmbH
 Tubulis GmbH Pharmaceuticals: MajorHealth Technology Tubulis GmbH engages in biotechnology company. The firm develops matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. The company was founded by Dominik Schumacher and Jonas Helma-Smets and is headquartered in Munich, Germany. | Président | 11/05/2021 |
Anciens postes connus de Christian Gröndahl
| Sociétés | Poste | Fin |
|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/01/2010 |
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | - |
Setisila Oy
 Setisila Oy Information Technology ServicesTechnology Services Setisila Oy develops and publishes software solutions for the processing of digital information. The firm specializes in the implementation of web applications, content management, and information systems. Its services include internet; intranet; extranet; needs assessment; concept and consulting services; project management; hosting services; maintenance contract; and training . The company was founded in 1998 and is headquartered in Helsinki, Finland. | Président | - |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Directeur Général | - |
| Kongeriget Danmarks Hesteforsikring G/S | Directeur/Membre du Conseil | - |
Formation de Christian Gröndahl
| University of Copenhagen | Doctorate Degree |
| International Institute for Management Development | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| ZEALAND PHARMA A/S | Health Technology |
| Entreprise privées | 7 |
|---|---|
Setisila Oy
Setisila Oy Information Technology ServicesTechnology Services Setisila Oy develops and publishes software solutions for the processing of digital information. The firm specializes in the implementation of web applications, content management, and information systems. Its services include internet; intranet; extranet; needs assessment; concept and consulting services; project management; hosting services; maintenance contract; and training . The company was founded in 1998 and is headquartered in Helsinki, Finland. | Technology Services |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Vitrolife A/S
Vitrolife A/S Industrial MachineryProducer Manufacturing Part of Vitrolife AB, Vitrolife A/S is a Danish company that manufactures laboratory equipment and customizes software. The company is based in Aarhus, Denmark. Kjær Andreasen has been the CEO of the company since 2014. Vitrolife was acquired by Vitrolife AB on November 26, 2014 for $84.11 million. | Producer Manufacturing |
| Kongeriget Danmarks Hesteforsikring G/S | |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Health Technology |
SNIPR Biome ApS
SNIPR Biome ApS Pharmaceuticals: MajorHealth Technology SNIPR Biome ApS develops bacterial composition to provide treatment for diabetes to cancer. The company was founded by Christian Grøndal and is headquartered in Kongens Lyngby, Denmark. | Health Technology |
Tubulis GmbH
Tubulis GmbH Pharmaceuticals: MajorHealth Technology Tubulis GmbH engages in biotechnology company. The firm develops matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. The company was founded by Dominik Schumacher and Jonas Helma-Smets and is headquartered in Munich, Germany. | Health Technology |